Safety, Tolerability, and Bioavailability of Subcutaneously Administered XmAb®7195

NCT02881853 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

57

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers
Atopic Disease

Interventions

DRUG: XmAb7195
DRUG: Placebo

Sponsor

Xencor, Inc.

Collaborators

[object Object]